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Abstract 28 
 29 
Objectives: An experimental reduction in physical activity is a useful tool for exploring the 30 
health benefits of physical activity. This study investigated whether similarly-active overweight 31 
men show a more pronounced response to reduced physical activity than their lean counterparts 32 
because of their athrogenic phenotype (i.e., greater abdominal adiposity). Methods: From 115 33 
active men aged 45-64 years, we recruited nine active lean (waist circumference <84 cm) and 34 
nine active central overweight men (waist circumference >94cm). Fasting blood samples and 35 
responses to an oral glucose tolerance test (OGTT) were measured at baseline and following one 36 
week of reduced physical activity to simulate sedentary levels (removal of structured exercise and 37 
reduced habitual physical activity). Results: Glucose and insulin areas under the curve (AUC), 38 
CRP, ALT, TAG were all higher in the overweight group and remained so throughout (P < 0.05). 39 
Insulin and glucose AUC responses to an OGTT, as well as fasting triglyceride (TAG) 40 
concentrations, increased in both groups as a result of the intervention (P < 0.05). There was no 41 
change in interleukin-6, C-reactive protein (CRP), Tumour Necrosis Factor-α, soluble 42 
intracellular adhesion molecule 1, or alanine transaminase (ALT). Conclusion: One-week of 43 
reduced activity similarly-impaired glucose control and increased fasting TAG in both lean and 44 
overweight men. Importantly, in spite of very similar (high) levels of habitual physical activity, 45 
central overweight men displayed a poorer profile for various inflammatory and metabolic 46 
outcomes (CRP, ALT, TAG, glucose AUC and insulin AUC).  47 
 48 
Keywords: Overweight, Abdominal adiposity, Physical Activity, Inflammation, Exercise 49 
 50 
 51 
 52 
 53 
 54 
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Introduction  76 
 77 
Exercise intervention studies generally support the notion that regular exercise lowers markers of 78 
inflammation and improves metabolic function; cf. [1]. Such studies demonstrate the impact of a 79 
positive change in behaviour (i.e., increased physical activity). An alternative experimental model 80 
that arguably more closely reflects the shift towards a more sedentary society is to examine the 81 
effects of reduced physical activity in active individuals [2].  82 
  83 
Even in young men, removal of structured exercise through short-term detraining leads to large 84 
changes in measures of glucose control [3] and lipid metabolism [4]. Furthermore, Gill et al [4] 85 
found an increase in tumour necrosis factor-α (TNF-α) over a one-week detraining period in 86 
young men. However, this study reported no change in Interleukin-6 (IL-6) and we recently 87 
reported that the removal of structured exercise in active middle-aged men had no impact on 88 
various markers of inflammation, including IL-6 [5]. Importantly, these studies sought to remove 89 
structured exercise in a classical view of ‘detraining’. However, even in regular exercisers, 90 
structured exercise represents only a small proportion of total physical activity energy 91 
expenditure [6, 7]. Arguably, a more powerful approach that better simulates true sedentary 92 
behaviour is to reduce total physical activity. Olsen et al. [8] and Krogh-Madsen et al. [9] 93 
achieved this by asking young, active (but untrained) subjects to reduce their daily step count 94 
(and hence total physical activity thermogenesis) over a two-week period. In these studies, 95 
various measures of insulin sensitivity deteriorated (e.g., plasma insulin area under the curve 96 
following an oral glucose tolerance test increased by 79%; [8]). Whilst there was no increase in 97 
markers of inflammation for this population, it is unclear whether this is also true for middle-aged 98 
participants who tend to have elevated circulating concentrations of inflammatory markers [10]. 99 
 100 
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Central adiposity is a risk factor for elevated markers of inflammation [11] and metabolic 101 
dysfunction [12]. It has been proposed that regular exercise is anti-inflammatory [13] and there 102 
has been some debate over whether it is possible to be ‘fat but fit’ [14].  It is conceivable that 103 
highly active individuals with increased central adiposity are protected against an increase in 104 
markers of inflammation and metabolic dysfunction because of their high physical activity [15, 105 
16]. In this context, we postulated that central overweight and lean middle-aged men with similar 106 
high levels of physical activity would have similar metabolic and inflammatory profiles; but, that 107 
a reduction of total physical activity to sedentary levels in central overweight active middle-aged 108 
men would lead to a rapid loss of metabolic and inflammatory homeostasis in comparison to their 109 
lean counterparts because of their greater central adiposity (i.e., the loss of physical activity 110 
would lead to a relatively greater disturbance because of their pro-atherogenic central adiposity 111 
phenotype). 112 
 113 
114 
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Materials and Methods 115 
 116 
Experimental Design 117 
In order to examine the interaction between adiposity and the impact of reduced physical activity 118 
in middle-aged men, we set out to recruit two groups of similar (highly) active middle-aged men; 119 
one lean group and one central overweight group. As discussed in more detail below, in order to 120 
be included in the study, men had to meet two separate criteria (i.e., being highly active as well as 121 
having a carefully defined level of central adiposity).  122 
 123 
Subjects 124 
Subjects were recruited via local advertisement following local National Health Service ethics 125 
approval and after subjects had given written informed consent. The sample size was determined 126 
using previous data which indicated a standard deviation of 0.51 pg/ml for fasting IL−6 [17]. 127 
Calculations showed that with 80% power and 5% alpha, 11 subjects were required in each group 128 
to detect a clinically relevant change in IL−6 of 0.6 pg/ml. Due to the low proportion of eligible 129 
subjects for the rigid criteria that were employed and high exclusion rate (described below), 130 
recruitment was terminated after 14 months when actual subject numbers were n = 9 men in each 131 
group. Subjects were 45-64 years old (Table 1). Exclusion criteria included smoking, current use 132 
of medication and/or presence of any co-morbidity (e.g., type 2 diabetes).  133 
 134 
After advertisement, 115 men considered themselves eligible and volunteered to take part (Figure 135 
1). Initial eligibility was via a questionnaire to determine whether subjects were likely to meet the 136 
physical activity requirements and measurement of waist circumference [18]. To ensure that 137 
groups differed in central adiposity, only individuals who had a waist circumference of less than 138 
84 cm [19] or greater than 94 cm (the cut-off point for increased risk of metabolic disease as 139 
defined by the WHO [20]) were recruited for the lean and overweight groups, respectively. 140 
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Central adiposity was used as an inclusion criterion as it has been shown to be a better predictor 141 
of obesity-related health risks than other measures such as BMI [12]. In subjects that were not 142 
excluded at this stage, physical activity energy expenditure was then estimated using 143 
synchronised accelerometry and heart rate (Actiheart, Cambridge Neurotechnology Ltd., 144 
Cambridge, UK). Subjects wore the monitor for seven whole consecutive days (day and night), 145 
recording data on a minute-by-minute basis [1, 21]. Subjects were instructed to remove the 146 
physical activity monitor only to change the electrodes. Subjects were not informed that the 147 
monitor recorded physical activity but that it recorded heart rate variability in order to avoid 148 
confounding from the Hawthorne effect (i.e., behavioural modification because of the act of 149 
being observed). Activity eligibility criteria were the same as those for active individuals in a 150 
previous study [17]. Briefly, this required participation in moderate/vigorous intensity activity for 151 
30 minutes or more 5 times a week and vigorous intensity activity for a total of 90 minutes per 152 
week; with no reported change in physical activity over the previous 6 months.   153 
 154 
Preliminary measures 155 
We assessed cardio−respiratory fitness using an incremental treadmill-based test as previously 156 
described [17]. Briefly, this involved an incremental incline test on a treadmill (Woodway, ELG 157 
Weiss, Germany) comprised of 3-min exercise stages with the incline increased by 3% at the end 158 
of each stage until volitional fatigue. We also took several anthropometric measurements (i.e., 159 
height, body mass, blood pressure), a fasted preliminary blood sample and performed a dual 160 
energy X-ray absorptiometry (DEXA; Discovery, Hologic, Bedford, UK) scan in order to 161 
estimate body composition. Whole body and central abdominal adipose masses (combined 162 
central abdominal subcutaneous and visceral adipose tissue; were estimated from the DEXA scan 163 
[22]). The preliminary blood sample was taken to exclude any individuals who had elevated 164 
markers of inflammation during the intervention period due to external factors (e.g., acute 165 
infection or injury). Values for all inflammatory markers were excluded for one subject in the 166 
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lean group based on his CRP concentration at baseline being 10 times that measured in the 167 
preliminary blood sample.   168 
 169 
Reduced physical activity week  170 
Subjects were asked to try and reduce their step count to less than 4000 steps/day for the one-171 
week intervention in order to replicate a sedentary lifestyle [23]. They were given a pedometer 172 
(Yamax Corp, Tokyo, Japan) to wear all day and asked to monitor their step count on a regular 173 
basis. Each subject was given a list of practical tips on how to reduce their step count. They were 174 
also instructed not to take part in any structured physical activity (i.e., playing sport, going to the 175 
gym). Subjects wore an Actiheart monitor during this period, so that physical activity level (PAL) 176 
and total energy expenditure (TEE) could be quantified [1, 21]. They were asked to maintain their 177 
normal diet during the intervention. 178 
 179 
Measurements 180 
On the morning of day 0 (baseline) and day 7, a venous blood sample was taken following an 181 
overnight fast (~12 h). An oral glucose tolerance test (OGTT) was then performed. Subjects 182 
consumed 75g of anhydrous glucose (113 ml of Polycal; Nutrica Clinical Care, Wiltshire, UK) 183 
and blood samples were taken, using finger prick blood sampling, every 15 minutes for the first 184 
hour and again after 2 hours. Two days before each trial day, subjects recorded their food and 185 
fluid intake. On the day before each trial day subjects were asked to refrain from the consumption 186 
of alcohol. Subjects were asked to perform a final typical structured moderate to vigorous 187 
intensity bout of exercise 36-48h before the start of the intervention and then to abstain from 188 
vigorous intensity exercise (this interval was introduced to reduce the likelihood that an acute 189 
increase in markers of inflammation would affect pre-intervention values [24]. 190 
 191 
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Analytical methods  192 
Subjects remained in a seated position 15 minutes prior to and during all blood sampling. 193 
Venepuncture blood samples were distributed into 5 ml plain and EDTA-treated tubes (Sarstedt 194 
Ltd., Leicester, UK). Whole blood glucose and lactate were measured using an automated 195 
analyzer (YSI 2300 STAT plus, Yellow Springs, OH). Blood cell counts were measured using an 196 
automatic hematology system (SF-3000, Sysmex, Milton Keynes, UK). Commercially available 197 
enzyme-linked immunosorbent assays (ELISA) were used to measure CRP (Diagnostic Systems 198 
Laboratories, Webster, TX), IL-6 (Quantikine, R & D Systems, Abingdon, UK), and soluble 199 
intercellular adhesion molecule-1 (sICAM-1; R & D Systems). Serum TNF- α and adiponectin 200 
were measured by ELISA (R & D systems Inc., Abingdon, UK). Immunoassays were used to 201 
measure plasma triglyceride (TAG), free fatty acids (FFA), alanine transaminase (ALT), total and 202 
high density lipoprotein (HDL) cholesterol (Cobas, Roche Diagnostics Limited, Burgess Hill, 203 
UK) and serum insulin (AutoDELFIA, Perkin Elmer, Waltham, Massachusetts, USA). Low 204 
density lipoprotein (LDL) cholesterol was calculated using the Friedewald equation [25]. During 205 
the OGTT, finger prick samples were obtained using a lancet (Accu-Check Softclix Pro, Roche, 206 
Lewes, UK). The first drop of blood was removed using a tissue and approximately 200 μl of 207 
whole blood was collected using a microvette tube coated with EDTA (CB300, Sarstedt Ltd) 208 
followed by another 200 μl of whole blood using a microvette tube coated with clot activator 209 
(CB300, Sarstedt Ltd).  From these capillary samples, whole blood glucose, plasma glucose and 210 
serum insulin were determined as described above.  211 
 212 
Statistical analysis 213 
Statistical analysis was performed using SPSS 14.0 for Windows (SPSS INC, Chicago, Illinois). 214 
All values are expressed as means ± SEM. Statistical significance was set at a value of P ≤ 0.05. 215 
Single baseline comparisons between groups were compared using t-tests. Two-way repeated 216 
measures ANOVA (repeated measures on time) were used to compare results between groups 217 
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over time. The area under the curve was calculated for glucose and insulin OGTT using the 218 
trapezium rule. All values were checked for normality using Kolmogorov-Smirnov and Shapiro-219 
Wilk tests. Any values that were not normally distributed were subsequently transformed. On one 220 
occasion, values could not be normally transformed (white blood cells; WBC). In this case, 221 
original values were used based on the assumption that ANOVA is robust to violations of the 222 
normality assumption, in that even when data are non-normal, the error is usually close to the 223 
desired value [26]. 224 
225 
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Results 226 
 227 
Descriptive measures 228 
Anthropometric and physiological descriptive data for the lean and overweight subjects are 229 
summarised in Table 1. Lean and overweight subjects were a similar age and height, and had a 230 
similar absolute maximal oxygen uptake and maximum oxygen uptake per kg fat free mass; but 231 
differed for all characteristics affected by adiposity (Table 1).  232 
 233 
Physical activity at baseline and during the intervention 234 
Pre-intervention and intervention physical activity energy expenditure (i.e., PAL) and step counts 235 
are shown in Figure 2. Importantly, the groups were similar at baseline with no significant 236 
difference in PAL, TEE or step counts (P = 0.422, 0.147 and 0.477 respectively). TEE was 237 
12953 ± 821 KJ/day for the lean group and 14485 ± 531 KJ/day for the overweight group pre-238 
intervention and 11242 ± 696 KJ/day for the lean group and 11173 ± 1573 KJ/day for the 239 
overweight group post-intervention. During the intervention, there was a significant decrease in 240 
PAL (P < 0.001), TEE (P = 0.001) and step counts (P < 0.001). Participants in both groups 241 
reduced their physical activity by similar amounts and there was no difference in any of these 242 
parameters between the two groups during the intervention week.   243 
 244 
Markers of inflammation 245 
There was no change in IL-6, CRP, TNF-α, sICAM-1, adiponectin, ALT or WBC count 246 
following reduced physical activity for 7 days (ANOVA time effect, P = 0.785, P = 0.230, P = 247 
0.340, P = 0.662, P = 0.076, P = 0.658, P = 0.569, respectively; Table 2). However, CRP and 248 
ALT were significantly higher in the overweight group compared to the lean group throughout 249 
the intervention despite the two groups having similar high physical activity energy expenditure 250 
(ANOVA group effect, P = 0.021 and P = 0.017, respectively). There was no significant 251 
† 
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difference in IL-6, TNF-α, sICAM-1, adiponectin or WBC count between the two groups 252 
(ANOVA group effect, P = 0.338, P = 0.292, P = 0.160, P = 0.123, P = 0.527, respectively; 253 
Table 2). There was no difference in the manner in which the two groups responded to the 254 
intervention for any of the inflammatory parameters (interaction effect; P = 0.560, 0.147, 0.618, 255 
0.727, 0.333 and 0.336 for IL-6, CRP, TNF-α, sICAM-1, adiponectin, ALT and WBC, 256 
respectively).  257 
 258 
Metabolic parameters 259 
Reduced physical activity increased the glucose and insulin area under the curve (AUC) and 260 
fasted TAG concentrations following the reduced physical activity week in both groups 261 
(ANOVA time effect P = 0.018, P = 0.001 and 0.021, respectively; Figure 3; Table 2, ANOVA 262 
interaction effect; P = 0.943, 0.252 and 0.372, respectively). There was no change in total, LDL 263 
or HDL cholesterol over the intervention period (P = 0.324, 0.323 and 0.075). The overweight 264 
group had a significantly higher glucose and insulin AUC and TAG concentrations (ANOVA 265 
group effect; P = 0.046, 0.021 and 0.035, respectively) throughout the intervention compared to 266 
the lean group and there was a trend for HDL cholesterol to be higher in the lean group (P = 267 
0.062). There was no significant difference in total and LDL cholesterol (P = 0.461 and 0.442 268 
respectively) between the two groups.  269 
 270 
271 
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Discussion 272 
 273 
We hypothesized that overweight active middle-aged men would show a greater increase in 274 
markers of inflammation and other cardiovascular disease risk factors in response to one week of 275 
reduced activity than similarly-active lean middle-aged men. Whilst various measures of glucose 276 
control decreased and TAG concentrations increased over the week of reduced activity, this 277 
occurred to the same magnitude in both lean and overweight groups and there was no significant 278 
change in markers of inflammation. Thus, in the short-term, central overweight and lean middle-279 
aged men respond similarly to a reduction in physical activity. Interestingly, in spite of similar 280 
(high) levels of physical activity, the overweight group had higher fasting markers of 281 
inflammation, TAG concentrations and a greater response to the OGTT (throughout).  282 
 283 
Due to our rigorous inclusion criteria, we successfully recruited two groups with different body 284 
composition but similar physical activity. Free-living physical activity energy expenditure was 285 
assessed using one of the best techniques currently available [1, 21]. Free-living habitual physical 286 
activity level (PAL) for both groups was classified as ‘active’ according to physical activity 287 
guidelines from the Institute of Medicine [27]. This is equivalent to greater than 1000 kcal per 288 
day being expended through physical activity. Moreover, all subjects exceeded established 289 
physical activity guidelines of 30 minutes of activity at an intensity greater than 3 METs 290 
(moderate intensity) five times per week or more [28]; and, all subjects performed structured 291 
vigorous intensity exercise lasting at least 30 minutes three times a week. There was no 292 
difference in physical activity between the two groups in terms of physical activity energy 293 
expenditure (PAL) and step count. Importantly, the intervention was successful in moving PAL 294 
well below the ‘active’ category [27] and step count was reduced to a level considered sedentary 295 
[23]. 296 
  297 
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As expected and in agreement with previous studies, we found a significant increase in insulin 298 
and glucose responses to an OGTT and fasting TAG concentrations over the week of reduced 299 
physical activity [8, 9]. In spite of these changes in metabolic markers, the one-week reduction in 300 
physical activity did not lead to a change in any marker of inflammation, in either group. In 301 
agreement with the current findings, previous research has found no change in several 302 
inflammatory markers (IL-6, CRP, TNF- α) in active, middle-aged men [5], and for IL-6 in active 303 
young men [4] following the removal of structured exercise for one week. In addition, Krogh-304 
Madsen et al [9] found no increase in IL-6 or TNF-α after two weeks of reduced physical activity 305 
in young men using a similar model (i.e., limiting step counts). These prior findings and those 306 
from the present study indicate that these markers are relatively stable in the face of short-term 307 
changes in physical activity.  308 
 309 
A key finding from the present study was that overweight middle-aged men had a more 310 
atherogenic profile than their lean counterparts for most of the risk factors we measured (CRP, 311 
ALT, TAG, glucose and insulin response to an OGTT) even though they expended considerable 312 
energy through participation in physical activity. Whilst epidemiological studies have previously 313 
suggested an association between body weight and markers of inflammation as well as other risk 314 
factors for cardiovascular disease (that is, independent of physical activity levels [11, 15]), these 315 
studies use less sensitive measures of physical activity (e.g. self-report questionnaires) and body 316 
fat (e.g. BMI) than those employed in the current study. The current findings extend these 317 
observations and improve the confidence with which we can conclude that adiposity (central 318 
and/or total) has a profound impact on health independent of precisely-measured physical 319 
activity. The effect of increased body fat on inflammation is likely to be attributed to the release 320 
of cytokines from adipose tissue [29]. Of course, from the present study design, we cannot 321 
determine whether high levels of physical activity ‘protected’ our overweight participants in 322 
comparison to a similarly overweight but sedentary population. Whilst we assume that this is the 323 
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case, the present results nevertheless indicate that high overall physical activity energy 324 
expenditure is not a direct substitute for leanness. With this in mind, a number of studies show 325 
that physical activity interventions only tend to reduce markers of inflammation when there is 326 
corresponding weight loss [30, 31]; although it is noteworthy that the reduction in fat mass by 327 
liposuction (i.e., without an energy deficit) does not lead to changes in markers of inflammation 328 
[32]. Clearly, whilst fat mass is independently important for various parameters, the effect may 329 
be secondary to adipose dysfunction (and function) rather than fat mass per se [33].  330 
   331 
In addition to baseline differences in glucose control and TAG between groups (discussed above) 332 
we found that both glucose and insulin responses to an OGTT and fasting TAG increased 333 
following the one-week reduced physical activity intervention in both groups. Importantly, the 334 
overweight group had a similar response (change) in comparison to their lean counterparts for 335 
these parameters. This suggests an independent (of fat mass) benefit from recent physical 336 
activity. Even one day of increased sitting has a profound effect on insulin action [34]. Thus, 337 
whilst a lean phenotype is clearly beneficial for a number of outcomes, it does not prevent the 338 
negative metabolic changes that occur in response to reduced physical activity.  339 
 340 
The current study design does not allow us to separate the effects of changes in energy balance 341 
during the intervention week from reduced physical activity per se. Assuming energy intake 342 
remained constant (participants were asked to maintain their normal diet), the reduced energy 343 
expenditure (due to reduced physical activity) would mean that subjects were in positive energy 344 
balance. Some studies have found the beneficial effects of exercise on metabolic factors have 345 
been attenuated when energy is replaced [35-37] and the short-term impact of increased sitting is 346 
also attenuated when energy intake is reduced [34]. Thus, energy balance may mediate some of 347 
the changes in TAG, glucose and insulin that occur with decreased physical activity. Whilst some 348 
studies indicate that energy restriction does not reduce postprandial TAG to the same magnitude 349 
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as energy-matched exercise the day before [38], other studies have shown that one day of energy 350 
restriction affects postprandial responses [39]. Thus, it is possible that in the current study that a 351 
more positive energy balance, rather than reduced physical activity per se, contributed to the 352 
poorer glucose control and increased TAG concentrations.  353 
 354 
We asked subjects to perform a typical bout of exercise 32 to 48h before the pre-intervention 355 
blood sample before abstaining from structured exercise until the baseline trial day. This was to 356 
allow markers of inflammation to return to baseline following any increase caused by acute 357 
exercise [24]. It is very difficult to determine the optimal time to abstain from exercise in these 358 
kinds of experiments. Since many of the parameters that changed in the current study (TAG, 359 
glucose and insulin concentrations) have been shown to be affected by acute exercise [40, 41], we 360 
cannot rule out that the lower values at baseline were the effect of the last exercise bout that are 361 
manifested as changes in response to the reduced physical activity intervention. This would not 362 
undermine the relative importance (and independence) of physical activity; but it would perhaps 363 
shift the emphasis onto acute behaviour in terms of very recent exercise or physical activity. 364 
Furthermore, we should highlight that we recruited overweight men based on a central adiposity 365 
phenotype and we cannot therefore determine whether differences due to adiposity are specific to 366 
this population.  367 
 368 
As described above, we recruited a slightly lower number of subjects than originally planned (9 369 
in each group rather than 11). This was due to difficulty in recruiting individuals who were met 370 
rigid pre-defined criteria (i.e, being very active and waist circumference < 84 cm or > 94 cm). 371 
Most subjects were not eligible for the study even after advertising for these specific groups. 372 
Importantly, post-hoc power calculations suggest that if we had recruited 11 per group this would 373 
not have made a difference to any of the findings. 374 
 375 
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In summary, in contrast to our hypothesis, we found that one week of reduced physical activity 376 
induced similar changes in glucose control (response to OGTT) and TAG in active lean and 377 
active overweight middle-aged men, with no changes in various markers of inflammation. 378 
Importantly, overweight middle-aged men had higher values for many parameters when 379 
compared to similarly-active lean middle-aged men (i.e., CRP, ALT, TAG, glucose and insulin 380 
response to an OGTT). Thus, an experimental reduction in physical activity leads to important 381 
and similar changes in both lean and overweight middle-aged men; but, these results also suggest 382 
that similar levels of habitual physical activity cannot completely override the negative impact of 383 
central adiposity.  384 
 385 
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Figure Legends  509 
 510 
Figure 1; Flow chart summarising subject recruitment and eligibility screening. 511 
 512 
Figure 2; Physical activity level (PAL; a) and daily step count (b; mean ± SE) over the lifestyle 513 
monitoring week (normal) and the reduced activity week (intervention) * significant change over 514 
time (p ≤ 0.05).  515 
 516 
Figure 3; Whole blood glucose concentrations (a), 2 h AUC (b), serum insulin concentrations 517 
(c), and 2 h AUC (d; mean ± SE) in response to the OGTT before and after the reduced physical 518 
activity week in lean (n=9) and overweight similarly-active middle-aged men (n=9). Samples 519 
were taken every 15 minutes for the first hour and then 2 h following the administration of 520 
glucose in lean and overweight subjects before (Day 0) and after a reduced physical activity 521 
intervention (Day 7). * Significant change in AUC over time, ‡ 2 h AUC significantly different 522 
between lean and overweight similarly-active middle-aged men. (P <0.05) 523 
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